title: Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma.
abstract: BACKGROUND
  Docosahexaenoic acid (DHA) found in fish oil is known to depress inflammation-related mediators. We investigated a novel delivery method of tridocosahexaenoyl-glycerol (DHA-TG).
  
  
  METHODS
  BALB/c mice (6-8 weeks old) were primed intraperitoneally with ovalbumin (OVA) and Al(OH)(3) on days 0 and 7, and with aerosolized OVA on day 7. Primed mice were challenged by repeated exposure to aerosolized OVA on days 15-17. Just before each exposure to aerosolized OVA, the mice were also exposed to an aerosol of emulsified DHA-TG or soybean oil, or saline (days 7 and 15-17). Bronchial hyperresponsiveness (BHR) to methacholine was measured, and bronchoalveolar lavage fluid was obtained 24 h after the last challenge (day 18). Lungs were histologically examined.
  
  
  RESULTS
  Bronchoalveolar lavage fluid of saline-treated mice showed an increased cellularity with predominant eosinophils. Exposure to DHA-TG significantly reduced the total cell number and the eosinophil percentage in lavage fluid, whereas soybean oil did not.
  
  
  CONCLUSIONS
  DHA but not soybean oil exposure reduced BHR and cell infiltration to bronchovascular bundles. This type of DHA administration could be studied in clinical trials.
authors.affiliation: Second Department of Internal Medicine, Ehime University, Onsen-gun, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Yokoyama
authors.forename: T
authors.initials: T
authors.lastname: Hamazaki
authors.forename: A
authors.initials: A
authors.lastname: Ohshita
authors.forename: N
authors.initials: N
authors.lastname: Kohno
authors.forename: K
authors.initials: K
authors.lastname: Sakai
authors.forename: G D
authors.initials: GD
authors.lastname: Zhao
authors.forename: H
authors.initials: H
authors.lastname: Katayama
authors.forename: K
authors.initials: K
authors.lastname: Hiwada
mesh_terms: D000336:Aerosols; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D016535:Bronchial Hyperreactivity; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D004195:Disease Models, Animal; D004281:Docosahexaenoic Acids / Q000008:administration & dosage*; D004655:Emulsions; D004804:Eosinophils / Q000187:drug effects; D005260:Female; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000336:Aerosols; D004655:Emulsions; D004281:Docosahexaenoic Acids; D010047:Ovalbumin